FURLAN, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 5.021
NA - Nord America 3.500
EU - Europa 1.960
SA - Sud America 1.314
AF - Africa 93
Totale 11.888
Nazione #
US - Stati Uniti d'America 3.330
SG - Singapore 2.224
CN - Cina 1.359
BR - Brasile 1.142
HK - Hong Kong 779
SE - Svezia 456
IT - Italia 373
RU - Federazione Russa 338
VN - Vietnam 283
DE - Germania 212
GB - Regno Unito 140
IN - India 91
CA - Canada 88
FI - Finlandia 87
AR - Argentina 70
AT - Austria 66
MX - Messico 65
NL - Olanda 61
PL - Polonia 59
BD - Bangladesh 54
ZA - Sudafrica 43
FR - Francia 38
IE - Irlanda 38
ES - Italia 35
JP - Giappone 35
EC - Ecuador 33
TR - Turchia 30
ID - Indonesia 28
IQ - Iraq 22
UA - Ucraina 16
VE - Venezuela 16
PK - Pakistan 15
PY - Paraguay 15
MA - Marocco 13
CO - Colombia 12
IR - Iran 12
SA - Arabia Saudita 12
UY - Uruguay 12
UZ - Uzbekistan 12
LT - Lituania 11
KE - Kenya 9
KR - Corea 8
TN - Tunisia 8
AZ - Azerbaigian 7
LB - Libano 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
CL - Cile 6
EG - Egitto 6
OM - Oman 6
BE - Belgio 5
DZ - Algeria 5
DO - Repubblica Dominicana 4
IL - Israele 4
NP - Nepal 4
SN - Senegal 4
BO - Bolivia 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
JO - Giordania 2
MY - Malesia 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 11.888
Città #
Singapore 984
Dallas 880
Hong Kong 773
Ashburn 499
Shanghai 346
Hefei 312
Beijing 195
Lawrence 174
Princeton 172
Los Angeles 145
New York 140
São Paulo 133
Milan 115
Ho Chi Minh City 105
Moscow 83
Nuremberg 67
Boardman 57
Warsaw 55
Hanoi 54
Munich 54
Helsinki 50
Washington 50
Santa Clara 42
Brooklyn 39
Chennai 39
Montreal 39
Dublin 37
Orem 37
Denver 36
London 34
Atlanta 33
Stockholm 33
Rio de Janeiro 31
Poplar 30
Turku 29
Manchester 27
Rome 27
Tokyo 27
Johannesburg 26
Seattle 26
Amsterdam 25
Chicago 25
Houston 24
Belo Horizonte 23
Vienna 23
Guangzhou 22
Mexico City 20
Phoenix 18
San Francisco 18
The Dalles 18
Toronto 18
Haiphong 17
Querétaro 17
Cesano Boscone 16
Curitiba 15
Boston 14
Brasília 14
Falkenstein 14
Ankara 13
Da Nang 13
Porto Alegre 13
Campinas 12
Guarulhos 12
Quito 12
Salvador 12
Charlotte 11
Dhaka 11
Frankfurt am Main 11
Naples 11
Shenzhen 11
Council Bluffs 10
Montevideo 10
Osasco 10
Tashkent 10
Xi'an 10
Betim 9
Caxias do Sul 9
Fortaleza 9
Jeddah 9
Kunming 9
Assago 8
Columbus 8
Hangzhou 8
Jaboatão dos Guararapes 8
Lappeenranta 8
Nairobi 8
Natal 8
Pune 8
Ribeirão Preto 8
Santo André 8
São José 8
Baku 7
Biên Hòa 7
Calgary 7
Goiânia 7
Guayaquil 7
Piracicaba 7
Reston 7
Trieste 7
Vancouver 7
Totale 6.764
Nome #
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 158
A peripheral inflammatory signature discriminates bipolar from unipolar depression: A machine learning approach 112
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors 109
Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up 106
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 103
Clinical Features and Biomarkers to Differentiate Primary and Amyotrophic Lateral Sclerosis in Patients With an Upper Motor Neuron Syndrome 82
Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study 82
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 80
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicantre study 79
A gene therapy approach to treat demyelinating diseases using nonreplicative herpetic vectors engineered to produce cytokines 78
Neuroinflammation in Bipolar Depression 78
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: A 2-year study 77
Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder 75
Classical and unconventional pathways of vesicular release in microglia 72
One-year mental health outcomes in a cohort of COVID-19 survivors 72
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis 71
Activation of invariant NKT cells by alpha GalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma 71
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 71
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients 70
A model of HTLV-I infection in the SCID mouse 69
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder 68
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 67
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 66
INCREASE OF MYELOID MICROVESICLES IN THE CEREBROSPINAL FLUID AS BIOMARKER OF MICROGLIA/MACROPHAGE ACTIVATION IN NEUROLOGICAL DISORDERS 64
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 63
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 63
miR-21 sustains CD28 signalling and low-affinity T-cell responses at the expense of self-tolerance 63
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 62
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers 61
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis 61
Activated macrophages release microvesicles containing polarized M1 or M2 mRNAs 61
In vivo fate analysis reveals the multipotent and self-renewal features of embryonic AspM expressing cells 60
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 60
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life 60
The microrna let-7b-5p is negatively associated with inflammation and disease severity in multiple sclerosis 60
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes. 59
CSF extracellular vesicles and risk of disease activity after a first demyelinating event 59
Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis 58
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates 58
Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis 58
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors 58
Dysregulation of MS risk genes and pathways at distinct stages of disease 57
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury 56
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 56
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder 56
Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects 55
Absence of immunoglobulin restriction in tears from multiple sclerosis patients 55
Inflammatory Markers Predict Blood Neurofilament Light Chain Levels in Acute COVID-19 Patients 55
Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice 55
A single nucleotide ADA genetic variant is associated to central inflammation and clinical presentation in MS: Implications for cladribine treatment 55
Absence of oligoclonally restricted immunoglobulins in tears from multiple sclerosis patients 55
Disease-modifying treatments modulate myeloid cells in multiple sclerosis patients 55
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease 55
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking 55
2D immunomic approach for the study of IgG autoantibodies in the experimental model of multiple sclerosis 55
ACID SPHINGOMYELINASE TRIGGERS P2X7-INDUCED MICROPARTICLE RELEASE FROM GLIAL CELLS 54
Acid sphingomyelinase activity triggers microparticle release from glial cells 54
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 54
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 54
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 54
iAstrocytes do not restrain T cell proliferation in vitro 53
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 53
Gene and stem cell therapy for autoimmune demyelination 53
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss 53
Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes 53
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS 52
Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis 52
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup 51
Acid sphingomyelinase activity triggers microparticle release from glial cells (vol 28, pg 1043, 2009) 51
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis 50
Administration of an MCP-1 variant to EAE mice prevents inflammatory cell recruitment and protects from demyelination and axonal loss 49
Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis 49
The unfolded protein response in amyotrophic later sclerosis: Results of a phase 2 trial 49
T regulatory cells are markers of disease activity in multiple sclerosis patients 48
Extracellular vesicles from adipose mesenchymal stem cells target inflamed lymph nodes in experimental autoimmune encephalomyelitis 47
PD-L2 identifies a novel subpopulation of neutrophils displaying immunoregulatory features in Multiple Sclerosis 47
Synapsin I deletion reduces neuronal damage and ameliorates clinical progression of experimental autoimmune encephalomyelitis 47
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression 47
PD-1/PD-L Axis in Neuroinflammation: New Insights 46
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis 46
Motor-evoked potentials (MEPs) for monitoring chronic cortico-spinal damage in MOG35-55-induced experimental autoimmune encephalomyelitis (EAE) 45
The impact of storage on extracellular vesicles: A systematic study 45
Ventilation With Argon Improves Survival With Good Neurological Recovery After Prolonged Untreated Cardiac Arrest in Pigs 45
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 45
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 44
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 44
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 43
ALTERED MRNA LEVELS OF CHEMOKINES AND CYTOKINES IN SCHIZOPHRENIA AND BIPOLAR DISORDER 43
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 43
MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis 43
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 43
Extracellular Vesicles in Neuroinflammation 42
Distinct protein expression networks are activated in microglia cells after stimulation with ifn and il-4 42
Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4 42
Artificial intelligence techniques in the diagnosis of multiple sclerosis 42
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents 42
Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis. 42
Highlights from the seventh international congress of the international society of neuroimmunology 41
Association between inflammation and brain microstructure in First Episode Psychosis investigated with DTI 41
Circulating cytotoxic immune cell composition, activation status and toxins expression associate with white matter microstructure in bipolar disorder 41
Totale 5.903
Categoria #
all - tutte 94.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 5 0 8 0 2 0
2021/2022162 6 4 1 57 14 18 16 5 7 15 7 12
2022/20231.070 398 175 50 6 8 85 37 49 28 24 201 9
2023/2024784 7 44 108 61 103 174 20 62 8 26 34 137
2024/20253.776 376 68 54 94 130 313 499 323 662 576 324 357
2025/20266.454 1.036 1.052 1.091 1.911 1.048 316 0 0 0 0 0 0
Totale 12.330